Brand Builder combines qualitative and quantitative methods to provide insight throughout the brand development process from mid-Phase III through to post-launch. It includes a diagnostic tool that profiles brand characteristics across five strategic dimensions. Based on that diagnostic evaluation, Brand Builder then delivers a customised research programme tailored to the needs of the brand.

“The first six months after launch often shapes the long-term success of a brand, and it’s increasingly important for pharmaceutical companies to get it right from the outset,” said Shirley Stoltenberg, director at Vivisum.

“Brand Builder provides insight into the needs of physicians, patients and payers, and enables marketers to optimise their launch strategy accordingly.”